Page last updated: 2024-08-26

lopinavir and Addiction, Opioid

lopinavir has been researched along with Addiction, Opioid in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Friedland, G; Jatlow, P; McCance-Katz, EF; Rainey, PM	1
Alvanzo, A; Baker, J; Friedland, G; Jatlow, P; McCance-Katz, EF; Moody, DE; Morse, GD; Pade, P; Rainey, PM; Smith, PF	1
Henney, JE	1
Back, DJ; Barry, M; Bergin, C; Boyle, N; Clarke, S; Mulcahy, F; Reynolds, H	1

Trials

1 trial(s) available for lopinavir and Addiction, Opioid

Article	Year
Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Apr-15, Volume: 34, Issue:8 Topics: Adult; Analgesics, Opioid; Drug Interactions; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Methadone; Opioid-Related Disorders; Pyrimidinones; Ritonavir; RNA, Viral; Substance Withdrawal Syndrome	2002

Article

Year

Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Apr-15, Volume: 34, Issue:8

Topics: Adult; Analgesics, Opioid; Drug Interactions; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Methadone; Opioid-Related Disorders; Pyrimidinones; Ritonavir; RNA, Viral; Substance Withdrawal Syndrome

2002

Other Studies

3 other study(ies) available for lopinavir and Addiction, Opioid

Article	Year
The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Aug-15, Volume: 37, Issue:4 Topics: HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Methadone; Narcotics; Opioid-Related Disorders; Pyrimidinones; Ritonavir; Substance Withdrawal Syndrome	2003
Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Dec-15, Volume: 43 Suppl 4 Topics: Adult; Buprenorphine; Case-Control Studies; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; HIV Protease Inhibitors; HIV Seronegativity; Humans; Lopinavir; Male; Narcotic Antagonists; Nelfinavir; Opioid-Related Disorders; Probability; Pyrimidinones; Reference Values; Risk Assessment; Ritonavir	2006
From the Food and Drug Administration. JAMA, 2000, Nov-01, Volume: 284, Issue:17 Topics: Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Buprenorphine; Child; Drug and Narcotic Control; Drug Combinations; Drugs, Investigational; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Leukemia, Promyelocytic, Acute; Lopinavir; Opioid-Related Disorders; Oxides; Pyrimidinones; Receptors, Opioid; Ritonavir; United States; United States Food and Drug Administration	2000